News Center

Home page

Peak Report

News reports

The company deploys the next phase of work

Release time:

2020-07-22

Efforts to Recover the Losses Caused by the Epidemic

Company Deploys the Next Phase of Work

News 4# October 16 , 17 , the company successively held work analysis meetings for pharmaceutical sector, cement sector and directly affiliated enterprises to summarize and take stock of the gains and losses of the work in the first quarter, requirements for this year's follow-up work, especially in the second quarter. At the

analysis meeting, the heads of the enterprises reported the work situation in the first quarter, focusing on the analysis of the existing problems, and put forward solutions and improvement plans. In the first quarter of this year, due to the outbreak of the new coronavirus pneumonia epidemic, the epidemic situation and prevention and control measures vary from place to place, the Spring Festival holiday was extended, the flow of people and logistics was blocked, the market was stagnant for a long time, and all business sectors of the company were affected to varying degrees. Since the resumption of work, the subordinate enterprises in earnest to do a good job in the prevention and control of the epidemic at the same time, to overcome many difficulties in efforts to resume work and production. In particular, the Daye Peak Cement Company, which is located in the central area of the epidemic, with the help and coordination of local government departments at all levels, organized manpower, scientifically arranged processes, and carried out a comprehensive overhaul of production equipment. Guizhou Peak, Peak Pharmaceutical Internationalization, Anhui New North Card - Zhongwang Phase II and other projects under construction have also overcome many difficulties and the project construction has returned to normal progress. Since the outbreak of the epidemic, there has been no case of infection in the whole group company, the state of mind of the employees is stable, and all production and operation work has been on the right track. At the

work analysis meeting, chairman Jiang Xiaomeng, general manager Yu Jianhong and other group company leaders commented on the work of each business sector one by one based on the economic and technical data of each enterprise in the first quarter, pointed out the highlights of the work, analyzed the problems and deficiencies, and put forward guidance and work requirements on how to further improve the work quality and minimize the losses caused by the epidemic in the second three quarters of this year.

Spike Pharmaceuticals: Catch Products, Reduce Costs, Strong Marketing

The meeting pointed out that the pharmaceutical industry has strong policy relevance, high technical requirements, and subsequent changes due to the epidemic are more complex. In view of the current actual situation of Jianfeng Pharmaceutical and the changing trend of the industry after the epidemic, it is necessary to concentrate superior resources according to the company's established development strategic objectives, and solidly cultivate the enterprise's own competitive advantages; further strengthen the internal integration of the enterprise, strengthen and build a streamlined and capable workforce; continue to strengthen process reengineering, and further straighten out every link from procurement, production to organizational structure establishment; go all out to break through the "intestinal obstruction" phenomenon in the whole process of product research and development, verification, production and listing; further optimize the sales team, strengthen the planning before the launch of new products, and strive for new breakthroughs in sales; further strengthen scientific and technological innovation, speed up the construction and optimization of R & D platform; do a good job in safety and environmental protection management with a "zero tolerance" attitude, improve the safety and environmental protection management system and process, and improve the staff awareness and related skills level. The

meeting pointed out that the impact of the epidemic, the import of pharmaceutical raw materials and intermediates has been blocked, objectively bringing new development opportunities to relevant domestic enterprises. North Carolina Company and its subordinate enterprises should pay attention to the management of production, quality and safety, and strive for more market opportunities in time.

Cement Plate: Strengthen Management, Reduce Costs, Set Advantages, and Seek Development

Among the company's various industrial plates, the cement plate is most obviously affected by business conditions. With the improvement of the epidemic prevention and control situation, the production and sales of two cement enterprises, Daye Peak and Yunnan Peak, have gradually returned to normal levels, and the construction of Guizhou Peak is also progressing steadily. The meeting pointed out that the current technological progress in the cement industry is very fast, and the future development of enterprises is facing severe challenges. The peak cement sector must arm itself from the control of management, technology and resources, and strive to establish advantages in market competition. We should further do a good job in fine management, standardized management and on-site rectification. In view of the fact that the current epidemic has not been completely lifted and the market is in a recovery period, we will impose management, maintenance and further expansion. After Daye Peak carries out system transformation, it is necessary to do a good job in equipment operation management to ensure that the equipment reaches the predetermined standard as soon as possible and improve the effective operation rate; at the same time, it is necessary to strengthen communication with local government departments at all levels to strive for further development. Yunnan Jianfeng should make great efforts to do a good job in mine renovation, and at the same time strengthen technical research and equipment technical transformation, and strive to reduce production costs.

International Trading Company: clear positioning, strong management, cost control, market expansion

Conference requires international trading companies to further change their management concepts, take existing business operations as a starting point, and comprehensively improve their management level; On the basis of innovative business models, further introduce new varieties, new customers and expand new businesses; Make good use of the qualifications of non-car carriers to expand new business areas; strengthen standardized management, further optimize management processes, reduce management and operating costs, and improve profitability.

Cable Company: Flexible response to the market and strengthening internal management

Conference requires cable companies to adapt to the characteristics of small quantity, small size and high standard of the current cable market in view of the new situation inside and outside the enterprise, and adjust and establish a stable business model by establishing a broad and long-term stable customer base. Do a good job in fine, standardized management and process control to reduce production and operation costs; strengthen the flexibility of production organization, further strengthen quality control and staff skills training, reduce costs by reducing the failure rate and unnecessary loss, improve the profit space, and strive for greater benefits.

Peak Health: Plug Loopholes, Grasp Standards, and Strengthen Responsibility

In view of the current operating situation of Peak Health, the meeting required the management team to carefully analyze the current situation and market, grasp the key points, and guide the future production and operation work with new ideas and new thinking. To further strengthen the sense of responsibility of every post and every employee, establish an overall management and control system for procurement, production, inventory, and sales, and strengthen the control of the entire process of operation and management; carefully analyze the advantages of its own products and technologies, and strive to find a breakthrough in sales work, maximize profitable business, and strive to reverse the operation Dilemma. The

meeting pointed out that the new coronary pneumonia epidemic will have a significant impact on the market structure, business model, and development trends of many industries. The management teams of the company's subsidiaries should promptly grasp the market trends and develop with a long-term development perspective. Work, and strive to further improve the quality of work in the next three quarters, and complete the work goals set at the beginning of the year. (this newspaper reporter)

More information

Yunnan peak through the safety standard secondary acceptance

On March 21, Yunnan Jianfeng Cement Company successfully passed the evaluation and acceptance of secondary enterprises for safety production standardization. On the same day, a review team composed of leaders of the Yunnan Provincial Work Safety Supervision Bureau and relevant experts reviewed the implementation of the establishment of Yunnan Jianfeng safety production standardization secondary enterprises. According to the 13 elements involved in the "Standard for Assessment and Rating of Safety Production Standardization in Cement Enterprises", the review team conducted strict assessment and scoring item by item through grouping to check the site and review the data, and finally determined that Yunnan Peak passed the standard acceptance of safety standardization secondary enterprises. Yunnan Jianfeng has always attached great importance to safety production. After passing the three-level safety standard enterprise review in 2015, in order to raise the level of enterprise safety management to a new level, in 2016, it began to create secondary safety standardization. Over the past year, Yunnan Jianfeng has insisted on taking the creation of secondary safety standards as the top priority of production and operation management, and has formulated an implementation plan for production safety standardization in accordance with the requirements of national standardization norms. the content covers production safety responsibility system, education and training, safety inspection, safety facilities management and other safety production management standards, systems and post safety operation procedures, while further strengthening daily safety inspection and regularly organizing emergency plan drills, strengthen the investigation and rectification of potential safety hazards and the supervision of important hazard sources, and further consolidate the foundation of enterprise safety production management. After the review, Zhou Jiping, general manager of Yunnan Jianfeng, said that Yunnan Jianfeng will take this standard as a new starting point. On the basis of consolidating the accident-free achievements in production safety for two consecutive years, it will conscientiously implement the main responsibility of production safety and cultivate

2020

07-30

Pharmaceutical Company Invests in Beihui Bio-Peak Pharmaceutical Plate to Expand its Territory

News from our newspaper On February 28, the 10th meeting of the 9th Board of Directors of the Group Company reviewed and approved the "Proposal on Foreign Investment of Subsidiaries" and the "Proposal on Authorizing the Chairman of the Board of Directors." On the same day, Jianfeng Pharmaceutical signed the "Agreement on Capital Increase and Share Transfer of Beijing Huibaoyuan Biotechnology Co., Ltd." and the "Performance Commitment Compensation Agreement" with relevant parties. It is planned to use Beijing Huibaoyuan Biotechnology Co., Ltd. (Beihui Biotechnology) and its holding subsidiary Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. (Guanghui Pharmaceutical) as a platform to jointly carry out new drug research and development, drug production and operation and other pharmaceutical business cooperation. Beihui Biological formerly known as Beijing Huibaoyuan Biotechnology Co., Ltd. The company has strong capabilities in new drug research and development. The actual controller is James Zhou (Zhou Hua), a returned entrepreneurial Ph.D. from Yale University in the United States, and hired Professor Zheng Yongqi from Yale University in the United States as the director of the Huibaoyuan Science and Technology Committee, focusing on anti-tumor and liver disease research. Through the cooperation with Yale University, we have obtained the patent authorization and commercial development license of the new anti-cancer chemical drug trasatabine (trokacitabine)(which has obtained the national new drug clinical approval in August 2016), the anti-hepatitis B chemical drug Crevudine (Clevudine). Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd., a subsidiary of Beihui Biology, is located in the third international park "China-Malaysia Qinzhou Industrial Park" jointly built by the Chinese government and foreign governments in Guangxi. It covers an area of 214.46 mu and has production workshops for multiple dosage forms such as percolation, tincture, solid preparations and liquid preparations.

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Fit" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original division model, combines all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Way to Work" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original business model, unifies all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Accident-free factory creation enters "second season"

At the beginning of the new year, a major "highlight" of the company's safety and environmental protection management in recent years-the "second quarter" of the establishment of a safety and environmental protection accident-free factory has also begun. Safety and environmental protection accident-free factory creation activities are an important measure for the company to improve the level of on-site management. The first phase of the activity will start on January 1, 2014 and end at the end of 2016 for a period of three years. Since the launch of the activity, all subordinate enterprises of the company have actively organized publicity and training related to safety and environmental protection, strengthened the awareness of safety and environmental protection of all employees, improved the management and operation level of safety and environmental protection; increased investment in safety and environmental protection facilities and equipment; strengthened safety and environmental protection inspection and self-examination and correction of hidden dangers, and timely organized rectification of hidden dangers; strictly assessed the units and relevant responsible persons of the accident, And the accident situation in the group, in order to arouse vigilance and avoid similar accidents. In the past three years, the company's subsidiaries have achieved remarkable results in standardization, safety, and clean operation. Safety and environmental protection accidents have dropped significantly, and no major accidents have occurred, which has effectively promoted the company's safe and civilized production construction. In the 2016 safety and environmental protection accident-free factory establishment assessment conducted a few days ago, a total of 6 units met the accident-free factory standard, of which Yunnan Jianfeng, Jianfeng International Trade and Pharmaceutical Department met the standard for the second consecutive year, and Daye Jianfeng, Qiubin Factory and Cable Company met the standard in the first year. In order to sum up experience and further improve the level of safety and environmental protection management, the Group decided to continue to open

2020

07-31

What will the Chinese Medicine Act bring us?

At the 25th meeting of the Standing Committee of the 12th National People's Congress in December 2016, the the People's Republic of China Chinese Medicine Law (hereinafter referred to as the Chinese Medicine Law) was deliberated and passed, which will come into effect on July 1 this year. As the first comprehensive law that comprehensively and systematically embodies the characteristics of traditional Chinese medicine, the Law of traditional Chinese Medicine clearly stipulates the service of traditional Chinese medicine, the protection and development of traditional Chinese medicine, the training of talents of traditional Chinese medicine, and the scientific research of traditional Chinese medicine. With the change of people's health concept and the continuous innovation of medical mode in recent years, the role of traditional Chinese medicine in health is becoming more and more important. The promulgation of the "Traditional Chinese Medicine Law" has made the development of Chinese medicine more law-based, and it is bound to bring changes to domestic pharmaceutical companies. So, the peak of the pharmaceutical, health products companies will look at the "Chinese Medicine Law", and will have how to deal with it? A few days ago, the reporter interviewed the pharmaceutical companies and peak health technology companies related to the person in charge. What will the Chinese Medicine Act bring us? Reporter: As the general manager of Peak Pharmaceutical, what do you think of the Chinese Medicine Law? Huang Jinlong (Deputy General Manager of the Group Company and General Manager of the Pharmaceutical Company): the Law of traditional Chinese Medicine defines the important position and development policy of traditional Chinese medicine. The state encourages traditional Chinese medicine and western medicine to learn from each other, complement each other, coordinate development, give full play to their respective advantages, and promote the integration of traditional Chinese and western medicine. Traditional Chinese medicine is a huge knowledge system, reflecting the Chinese nation's understanding of life, health and disease. It is precisely because of the distinctive characteristics of Chinese medicine that the Law of Chinese Medicine is used in Chinese medicine clinics, Chinese medicine physicians and doctors.

2020

07-31

< 1...49 50 51...61 > 跳转到页